Stage IIIA cutaneous melanoma ajcc V7
Clinical trials for Stage IIIA cutaneous melanoma ajcc V7 explained in plain language.
Never miss a new study
Get alerted when new Stage IIIA cutaneous melanoma ajcc V7 trials appear
Sign up with your email to follow new studies for Stage IIIA cutaneous melanoma ajcc V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost immune attack on melanoma
Disease control CompletedThis early-phase trial is testing whether combining two drugs—pembrolizumab (Keytruda) and ibrutinib (Imbruvica)—can safely treat advanced melanoma that cannot be removed by surgery. Pembrolizumab helps the immune system fight cancer, while ibrutinib blocks enzymes that help canc…
Matched conditions: STAGE IIIA CUTANEOUS MELANOMA AJCC V7
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Double immune attack: new combo therapy shows promise for tough melanoma
Disease control CompletedThis study tested two different doses of the immunotherapy drug ipilimumab, either alone or combined with high-dose interferon, in 88 people with advanced melanoma that could not be surgically removed. The goal was to see if the combination could delay cancer growth better than i…
Matched conditions: STAGE IIIA CUTANEOUS MELANOMA AJCC V7
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a vaccine keep melanoma from coming back? large trial tests immune boosters
Disease control CompletedThis phase 3 trial tested whether a yeast-derived immune stimulant (GM-CSF) and a peptide vaccine, alone or together, could prevent melanoma from returning after surgery. 815 patients with no visible cancer after complete surgical removal of advanced melanoma were randomly assign…
Matched conditions: STAGE IIIA CUTANEOUS MELANOMA AJCC V7
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC